HP
TEVA icon

Havemeyer Place’s Teva Pharmaceuticals TEVA Stock Holding History

Havemeyer Place’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.32M Sell
38,883
-17,812
-31% -$593K 0.13% 258
2026
Q1 		$1.71M Sell
56,695
-4,583
-7% -$147K 0.2% 189
2025
Q4 		$1.91M Buy
+61,278
New +$1.51M 0.38% 72

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Havemeyer Place's TEVA Position: Q2 2026 in Review

Havemeyer Place reduced its Teva Pharmaceuticals (TEVA) stake by 31% in Q2 2026, selling an estimated $593K and leaving 38,883 shares worth $1.32M. The position accounts for 0.13% of the portfolio, ranked #258.

Havemeyer Place first reported a position in TEVA in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.91M in Q4 2025. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Havemeyer Place held 38,883 shares of Teva Pharmaceuticals worth $1.32M as of Q2 2026.
  • Havemeyer Place sold 17,812 Teva Pharmaceuticals shares in Q2 2026, an estimated $593K.
  • Teva Pharmaceuticals made up 0.13% of Havemeyer Place's portfolio in Q2 2026, its #258 holding.
  • Havemeyer Place first reported a position in Teva Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Havemeyer Place's Teva Pharmaceuticals position peaked at $1.91M in Q4 2025.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Havemeyer Place's 13F filing for Q2 2026, filed 13 Aug 2026.